16 /100
LOW RISK
Score updated Jul 13, 2026

MBLY — Mobileye Global Inc. Dilution Risk Tracker

Track MBLY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MBLY — Get alerts when the score changes →

As of July 13, 2026, Mobileye Global Inc. (MBLY) has a DilutionWatch DilutionScore of 16/100, rated LOW dilution risk. Mobileye Global Inc. has a market capitalization of $8.71B, 244.42M shares outstanding, 296 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
32
💰 Cash Runway
0
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MBLY.
🔔 Track MBLY — Get forecast alerts →

💹 Market Data

Market Cap$8.71B
Shares Outstanding244.42M
Float167.48M
Cash$1.21B
Debt$62.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 5.9% shares (2026Q1 vs prior)
296 institutional holders · 227.14M shares
#1 Intel Corp 50.00M shares
#2 GOLDMAN SACHS GROUP INC 18.88M shares
#3 MANUFACTURERS LIFE INSURANCE COMPANY, THE 10.31M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest32.19M
Days to Cover4.6
% of Float19.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for MBLY Shareholders

Mobileye Global Inc. (MBLY) has a DilutionScore of 16/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MBLY shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MBLY in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MBLY alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MBLY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MBLY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MBLY
📊 MBLY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MBLY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.